---
title: "Novo Nordisk AS signs a $2.1 billion licensing agreement"
description: "On October 15th, Danish pharmaceutical company Novo Nordisk and American biotechnology company Omeros announced that they have signed a licensing agreement worth up to $2.1 billion, under which Novo N"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261291274.md"
published_at: "2025-10-15T15:18:53.000Z"
---

# Novo Nordisk AS signs a $2.1 billion licensing agreement

> On October 15th, Danish pharmaceutical company Novo Nordisk and American biotechnology company Omeros announced that they have signed a licensing agreement worth up to $2.1 billion, under which Novo Nordisk will obtain a drug being developed by Omeros for the treatment of rare blood and kidney diseases

On October 15th, Danish pharmaceutical company Novo Nordisk and American biotechnology company Omeros announced that they have signed a licensing agreement worth up to $2.1 billion, under which Novo Nordisk will obtain a drug being developed by Omeros for the treatment of rare blood and kidney diseases

### Related Stocks

- [NVO.US - Novo Nordisk AS](https://longbridge.com/en/quote/NVO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock? | As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock? | [Link](https://longbridge.com/en/news/270794581.md) |
| Novo Nordisk (NVO) Rethinks Pricing as Compounded GLP-1 Drugs Gain Ground | Novo Nordisk CEO Mike Doustdar announced that 1.5 million people in the U.S. are using compounded GLP-1 weight-loss drug | [Link](https://longbridge.com/en/news/272307926.md) |
| SolarEdge Technologies Q4 Earnings Report: What Investors Need to Know | SolarEdge Technologies (NASDAQ:SEDG) reported Q4 earnings on February 18, 2026, beating estimates by 64.1% with an EPS o | [Link](https://longbridge.com/en/news/276229789.md) |
| Ingalls & Snyder LLC Sells 6,891 Shares of Oracle Corporation $ORCL | Ingalls & Snyder LLC reduced its stake in Oracle Corporation (NYSE:ORCL) by 12.9% in Q3, selling 6,891 shares, leaving t | [Link](https://longbridge.com/en/news/276218440.md) |
| BUZZ-Hecla Mining up after upbeat results, Casa Berardi sale announcement | Hecla Mining shares rose 5.6% premarket to $22.43 following a strong Q4 report, with revenue up 83% year-over-year to $4 | [Link](https://longbridge.com/en/news/276217251.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.